Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis

L Asadi, WI Sligl, DT Eurich, IN Colmers… - Clinical Infectious …, 2012 - academic.oup.com
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

[PDF][PDF] Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

L Asadi, WI Sligl, DT Eurich, IN Colmers… - Clinical Infectious …, 2012 - rumedo.ru
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

[PDF][PDF] Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

L Asadi, WI Sligl, DT Eurich, IN Colmers… - Clinical Infectious …, 2012 - academia.edu
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis

L Asadi, WI Sligl, DT Eurich… - … publication of the …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

[PDF][PDF] Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

L Asadi, WI Sligl, DT Eurich, IN Colmers… - Clinical Infectious …, 2012 - rumedo.ru
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.

L Asadi, WI Sligl, DT Eurich, IN Colmers… - … Diseases: an Official …, 2012 - europepmc.org
Background Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

[PDF][PDF] Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

L Asadi, WI Sligl, DT Eurich, IN Colmers… - Clinical Infectious …, 2012 - researchgate.net
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.

L Asadi, WI Sligl, DT Eurich, IN Colmers, L Tjosvold… - 2012 - cabidigitallibrary.org
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

[PDF][PDF] Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

L Asadi, WI Sligl, DT Eurich, IN Colmers, L Tjosvold… - 2012 - Citeseer
Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

L Asadi, WI Sligl, DT Eurich… - Clinical Infectious …, 2012 - search.ebscohost.com
Macrolide-based regimens were associated with a significant 22% reduction in mortality
compared with nonmacrolides in 137 574 hospitalized patients with community-acquired …